(1)
Cao, R.; Du, W.; Lin, B. Comparison and Synergy of IVAC and CRISPR-Related Tumor Immune Strategies: Value Reassessment Under A Zero Genome Risk Reference. IJBLS 2026, 17 (2), 44-51. https://doi.org/10.54097/pnqcf426.